Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Retatrutide 30mg Dosage Chart: IU Per Dose at 10mg/mL
articleThe 30mg-in-hand reference. Reconstitute with 3mL BAC water for 10mg/mL, then read the 4-step IU titration ladder for every titration dose from 2mg through 12mg on a U-100 insulin syringe.
Tirzepatide Dosing in Units: Master Chart for All 4 Vial Sizes
articleThe complete tirzepatide unit conversion reference. 24-cell master table covering 5mg, 10mg, 15mg, and 30mg vials at every titration dose from 2.5mg through 15mg on U-100 insulin syringes.
Semaglutide Dosing in Units: Dual-Ladder Chart for Ozempic and Wegovy
articleThe complete dual-ladder semaglutide unit conversion reference. Master IU table covering the Wegovy weight-loss titration (0.25 to 2.4 mg) and the Ozempic T2D titration (0.25 to 1.0 mg, optional 2.0 mg) at 2.5 mg/mL and 5 mg/mL.